Paolo Corradini appointed Chairman of the AIL Scientific Committee, Franco Locatelli new component

ROMA (ITALPRESS) – Renewed the Scientific Committee of AIL – Italian Association against Leucemie, Linfomi and Mieloma – with the appointment of Paolo Corradini to the Presidency, and Franco Locatelli new member.

Already a member of the Scientific Committee AIL, Paolo Corradini, Professor of Ethology University of Milan, Director of Ethology and Scientific Director f.f. of the National Institute of Tumors of Milan, was elected President by the members of the Scientific Committee, as provided by the Statute of the Association.

Director of the Clinical Area of Onco-Emathology Pediatric, Cellular Therapy, Genic Therapies and Emopoietic Transplantation of the Child Hospital Jesus of Rome and Ordinary Professor of Pediatrics at the Catholic University of the Sacred Heart of Rome, Franco Locatelli is one of the leading international experts in the field of pediatric hematology, stem cell transplantation.

“The appointments of Professor Paolo Corradini and Professor Franco Locatelli represent a moment of absolute value for our Association”, comments Giuseppe Toro, National President AIL. “The AIL Scientific Committee includes professionals of great authority and recognized international prestige, who with their expertise and experience contribute to supporting AIL in the choices related to the study and research and definition of investment priorities. I address, on behalf of our entire Association, the best wishes for good work, of course, that their contribution will be extremely valuable to continue to promote and support a scientific research of excellence in the service of patients suffering from blood cancer”.

“I would like first of all to thank AIL and the Scientific Committee for the trust they have granted me with the appointment as President of the Scientific Committee,” Corradini says. “I welcome this task with a great sense of responsibility, aware of the importance of the role, and with the aim of contributing to further consolidate and increase the quality of clinical and biological research that AIL promotes and supports, in the interest of patients suffering from hematological diseases. In recent years, the scientific activity of the Association has experienced significant growth, as demonstrated by the AIL Research Bands, which have become increasingly qualified, competitive and excellence-oriented instruments,” continues Corradini.

“In this path, the entry into the Scientific Committee of Prof. Franco Locatelli is an important added value for its scientific expertise and the ability to promote high profile research. I would also like to thank Prof. William Arcese for the valuable work of the Scientific Committee, through which the great scientific rigour and authoritativeness of the Committee were strengthened. With the contribution of all the prestigious members of the Scientific Committee, I hope to continue on this path, promoting new strategies and new development opportunities for AIL’s scientific activity, with the aim of making research support more effective and translating its results into concrete and lasting benefits for patients and their families.”.

“It is a great pleasure for me, as well as a privilege, to become a member of the Scientific Committee of AIL, of which colleagues and friends of great value belong,” says Professor Franco Locatelli. “AIL, born in large part on the initiative of a real giant like Professor Franco Mandelli, has for years been known, among other activities, for its extraordinary ability to promote clinical and translational research in favor of patients suffering from hematological neoplasms, as well as to help support the first steps of the best talents who study and analyze the malignant pathologies of blood. To contribute to a further growth of AIL’s activities is a real reason for pride and for this purpose I will certainly dedicate my best resources.”.

After the renewal, the Scientific Committee AIL is composed of: – Paolo Corradini, President – Professor of Emathology University of Milan, Director of Emathology and Scientific Director of the National Institute of Tumors of Milan; – Franco Locatelli – Director Clinical Area of Onco-Emathology Pediatric, Cellular Therapy, Genic Therapy and Emopathology Federico II of Naples; – Alessandro Rambaldi – Professor of Hematology, Scientific Director Foundation for Research- FROM, Pope John XXIII Hospital in Bergamo; – Giorgina Specchia – Professor of Hematology and President of the Apulian Ematological Network Guarantee.

– Press office photos AIL –
(ITALPRESS).

Scroll to Top